Literature DB >> 17187778

Eukaryotic translation initiation factor 5A induces apoptosis in colon cancer cells and associates with the nucleus in response to tumour necrosis factor alpha signalling.

Catherine A Taylor1, Zhong Sun, Dominic O Cliche, Hong Ming, Bithi Eshaque, Songmu Jin, Marianne T Hopkins, Boun Thai, John E Thompson.   

Abstract

Eukaryotic translation initiation factor 5A (eIF5A) is thought to function as a nucleocytoplasmic shuttle protein. There are reports of its involvement in cell proliferation, and more recently it has also been implicated in the regulation of apoptosis. In the present study, we examined the effects of eIF5A over-expression on apoptosis and of siRNA-mediated suppression of eIF5A on expression of the tumour suppressor protein, p53. Over-expression of either eIF5A or a mutant of eIF5A incapable of being hypusinated was found to induce apoptosis in colon carcinoma cells. Our results also indicate that eIF5A is required for expression of p53 following the induction of apoptosis by treatment with Actinomycin D. Depiction of eIF5A localization by indirect immunofluorescence has indicated, for the first time, that the protein is rapidly translocated from the cytoplasm to the nucleus by death receptor activation or following treatment with Actinomycin D. These findings collectively indicate that unhypusinated eIF5A may have pro-apoptotic functions and that eIF5A is rapidly translocated to the nucleus following the induction of apoptotic cell death.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17187778     DOI: 10.1016/j.yexcr.2006.09.030

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  40 in total

1.  The role of Lamin A in cytoskeleton organization in colorectal cancer cells: a proteomic investigation.

Authors:  Clare R Foster; Joanne L Robson; William J Simon; Jeremy Twigg; Derek Cruikshank; Robert G Wilson; Chris J Hutchison
Journal:  Nucleus       Date:  2011-09-01       Impact factor: 4.197

2.  The unique hypusine modification of eIF5A promotes islet beta cell inflammation and dysfunction in mice.

Authors:  Bernhard Maier; Takeshi Ogihara; Anthony P Trace; Sarah A Tersey; Reiesha D Robbins; Swarup K Chakrabarti; Craig S Nunemaker; Natalie D Stull; Catherine A Taylor; John E Thompson; Richard S Dondero; Eli C Lewis; Charles A Dinarello; Jerry L Nadler; Raghavendra G Mirmira
Journal:  J Clin Invest       Date:  2010-05-24       Impact factor: 14.808

Review 3.  Targeting the polyamine-hypusine circuit for the prevention and treatment of cancer.

Authors:  Shima Nakanishi; John L Cleveland
Journal:  Amino Acids       Date:  2016-06-29       Impact factor: 3.520

Review 4.  The translation factor eIF5A and human cancer.

Authors:  Michael B Mathews; John W B Hershey
Journal:  Biochim Biophys Acta       Date:  2015-05-13

5.  Inhibition of eIF5A results in aberrant uterine natural killer cell function and embryo loss in mice.

Authors:  Xiaoli Qin; Xiaorui Liu; Bin Shan; Lijuan Shi; Surendra Sharma; Ji Wu; Yi Lin
Journal:  Am J Reprod Immunol       Date:  2014-01-02       Impact factor: 3.886

6.  Synthetic lethality between eIF5A and Ypt1 reveals a connection between translation and the secretory pathway in yeast.

Authors:  Mariana C Frigieri; Marcus V S João Luiz; Luciano H Apponi; Cleslei F Zanelli; Sandro R Valentini
Journal:  Mol Genet Genomics       Date:  2008-06-21       Impact factor: 3.291

7.  Esophageal cancer alters the expression of nuclear pore complex binding protein Hsc70 and eIF5A-1.

Authors:  Mehdi Moghanibashi; Ferdous Rastgar Jazii; Zahra-Soheila Soheili; Maryam Zare; Aliasghar Karkhane; Kazem Parivar; Parisa Mohamadynejad
Journal:  Funct Integr Genomics       Date:  2013-03-29       Impact factor: 3.410

8.  Proteome changes in human bronchoalveolar cells following styrene exposure indicate involvement of oxidative stress in the molecular-response mechanism.

Authors:  Nora Mörbt; Iljana Mögel; Stefan Kalkhof; Ralph Feltens; Carmen Röder-Stolinski; Jiang Zheng; Carsten Vogt; Irina Lehmann; Martin von Bergen
Journal:  Proteomics       Date:  2009-11       Impact factor: 3.984

9.  Inhibition of HIV-1 gene expression by Ciclopirox and Deferiprone, drugs that prevent hypusination of eukaryotic initiation factor 5A.

Authors:  Mainul Hoque; Hartmut M Hanauske-Abel; Paul Palumbo; Deepti Saxena; Darlene D'Alliessi Gandolfi; Myung Hee Park; Tsafi Pe'ery; Michael B Mathews
Journal:  Retrovirology       Date:  2009-10-13       Impact factor: 4.602

10.  An update on the mouse liver proteome.

Authors:  Giuseppe Gazzana; Jürgen Borlak
Journal:  Proteome Sci       Date:  2009-09-08       Impact factor: 2.480

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.